| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/04/2007 | CN1939480A Chinese-medicinal compound preparation for treating injury |
| 04/04/2007 | CN1939479A Multi-effect herbal hair-regenerating liquor |
| 04/04/2007 | CN1939470A Chinese medicinal plaster with analgetic, hemostatic repercussive and sore-arresting functions |
| 04/04/2007 | CN1939463A Chinese-medicinal preparationf or treating leucoderma |
| 04/04/2007 | CN1939455A Medicine for treating scalding without scar |
| 04/04/2007 | CN1939442A Medicated liquor for treating furunculosis |
| 04/04/2007 | CN1939441A Medicinal composition for treating burn and scald and its preparation |
| 04/04/2007 | CN1939426A Compound medicine for treating skin scald, insult and sore and its preparation |
| 04/04/2007 | CN1939425A Animal medicament with heat-clearing, toxin-removing, blood-cooling and stasis-dispelling functions and its production |
| 04/04/2007 | CN1939397A Jiaoqijing and its preparation |
| 04/04/2007 | CN1939381A Animal medicament with heat-clearing, toxin-removing, wind-dispersing and obstruction-removing functions and its making method |
| 04/04/2007 | CN1939354A Medicine for treating burn and scald |
| 04/04/2007 | CN1939340A 脂质体制剂 Liposomal formulations |
| 04/04/2007 | CN1939337A Compositions, uses and kits for treating allergic dermatitis of skin |
| 04/04/2007 | CN1939327A Pharmaceutical usage of neolinarin, linarin and their composition |
| 04/04/2007 | CN1939324A Medical usage of periplocin A and E |
| 04/04/2007 | CN1939319A Isoglycyrrhiza acid magnesium externally-applied preparation, its making method and usage |
| 04/04/2007 | CN1939317A Isoglycyrrhiza acid magnesium preparation for vein and its making method |
| 04/04/2007 | CN1939313A Externally-applied preparation for treating trauma |
| 04/04/2007 | CN1939295A Baical skullcap root dropping balls and making method thereof |
| 04/04/2007 | CN1939288A Composite acne-inhibiting pellicle |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
| 04/04/2007 | CN1308030C Pharmaceutical composition containing effective part of 'Ruyi Jinhuang Powder' and preparation method thereof |
| 04/04/2007 | CN1308027C Medicinal formulation for treating skin tinea |
| 04/04/2007 | CN1307993C Macrolides-containing pharmaceutical compositions |
| 04/04/2007 | CN1307971C Antimycotic nail varnish composition |
| 04/04/2007 | CN1307970C Silica-coated mixed crystal oxide particle, production process thereof and cosmetic material using the same |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199219 Polypeptides derived from vitamin D nuclear receptor, and their uses in particular for screening vitamin D analogues |
| 04/03/2007 | US7199159 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7199122 Administering 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione and/or metabolite thereof; treating neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade |
| 04/03/2007 | US7198800 spray on skin patch drug delivery system; substantially water insoluble film forming agent; film plasticiser agent; water soluble compound; and organic solvent |
| 04/03/2007 | US7198254 System for producing micro-cluster liquids |
| 04/03/2007 | CA2417279C Treatment of hyperproliferative skin disorders and diseases |
| 04/03/2007 | CA2388452C Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 04/03/2007 | CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 04/03/2007 | CA2205275C Vitamin d3 analogs |
| 04/03/2007 | CA2183430C Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
| 04/03/2007 | CA2180660C Novel piperidine derivatives with paf antagonist activity |
| 04/03/2007 | CA2176510C Method for preparing concentrated biologically active silicon compounds |
| 04/03/2007 | CA2108770C Bmp-9 compositions |
| 03/29/2007 | WO2007034927A1 Medicine, food and drink or feed containing sphingomyelin |
| 03/29/2007 | WO2007034917A1 Novel adenine compound |
| 03/29/2007 | WO2007034916A1 Novel adenine compound |
| 03/29/2007 | WO2007034882A1 Novel adenine compound |
| 03/29/2007 | WO2007034881A1 Novel adenine compound |
| 03/29/2007 | WO2007034817A1 Novel adenine compound |
| 03/29/2007 | WO2007034736A1 Adhesive skin patch |
| 03/29/2007 | WO2007034323A1 Composition for use in treatment of hair balding, thinning and loss and method for same |
| 03/29/2007 | WO2007010294A3 Use of delmopinol in the treatment of acne |
| 03/29/2007 | WO2007006549A3 Oligomers of cholesterol, cholesterol sulfate and cholesterol esters, and medicaments containing the same |
| 03/29/2007 | WO2007003768A3 Use of an extract of the species trigonella foenum graecum in a cosmetic or pharmaceutical composition |
| 03/29/2007 | WO2006108949A3 Novel use of zinc gluconate for treating hydradenitis suppurativa |
| 03/29/2007 | WO2006102681A3 Method of treating skin ulcers using oxidative reductive potential water solution |
| 03/29/2007 | US20070072849 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
| 03/29/2007 | US20070072835 Method of preparing and use of prodrugs of betulinic acid derivatives |
| 03/29/2007 | US20070072820 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070072819 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/29/2007 | US20070072818 Endothelial growth factors; antiischemic agents; neovascularization |
| 03/29/2007 | US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 03/29/2007 | US20070072291 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 03/29/2007 | US20070071830 Method for increasing bioavailability of lipophilic bioactive compounds |
| 03/29/2007 | DE202006019122U1 Pflege- und Heilöl zur Behandlung trockener, wunder, stark beanspruchter Haut Care and healing oil for treating dry, sore, stretched skin |
| 03/29/2007 | DE102005058978A1 Wund- und Schleimhautdesinfektionsmittel Wound and mucous membrane disinfectant |
| 03/29/2007 | DE102005045989A1 Powder base, useful for e.g. protecting the skin from disorders, comprises e.g. protective material, mineral pigment, different organic materials, urea, antimicrobial-, antiseptic-, anitinflammatory- and itch protective- agents |
| 03/29/2007 | CA2623529A1 Pdgf amphiphilic polymer complex |
| 03/29/2007 | CA2623304A1 Medicine, food and drink or feed containing sphingomyelin |
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor |
| 03/28/2007 | EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/28/2007 | EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor |
| 03/28/2007 | EP1767218A1 Antiinflammatory and analgesic preparation for external use |
| 03/28/2007 | EP1767200A1 Antiaging agent |
| 03/28/2007 | EP1767198A1 Regulator of physiological function of ghrelin and use thereof |
| 03/28/2007 | EP1765368A1 Methods and compositions for wound healing |
| 03/28/2007 | EP1765366A2 Sulphated depolymerised derivates of exopolysaccharides (eps), preparation and uses thereof |
| 03/28/2007 | EP1765358A2 Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones |
| 03/28/2007 | EP1765356A1 Spray composition comprising a combination of calcitriol and clobetasol propionate, an alcoholic phase, at least one volatile silicone and one non volatile oily phase |
| 03/28/2007 | EP1765341A2 Methods of treating cellular proliferative disease using naphthalimide and parp-1 inhibitors |
| 03/28/2007 | EP1765336A2 Angiogenesis inhibitors |
| 03/28/2007 | EP1499312B1 The use of hydroxypyridone-derivatives in wound healing |
| 03/28/2007 | EP1497294B1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 03/28/2007 | EP1284134B1 External skin preparations for suppressing sebum secretion |
| 03/28/2007 | CN1938318A Process for producing flavone C glycoside derivatives |
| 03/28/2007 | CN1938299A Thioamide derivatives as progesterone receptor modulators |
| 03/28/2007 | CN1938039A Agent improving moisture-retention function of skin |
| 03/28/2007 | CN1938033A Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle |
| 03/28/2007 | CN1938028A Anti-itching agent |
| 03/28/2007 | CN1938025A Angiogenesis-affecting compounds and methods of use thereof |
| 03/28/2007 | CN1938019A Protein kinase C inhibitors for the treatment of autoimmune diseases and of transplant rejection |
| 03/28/2007 | CN1938012A External preparation |